Cargando…
The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
BACKGROUND: Cancer has always been a serious health threat for human. Patients with cancer are at high risk of drug-related problems (DRPs) due to multi-morbidity associated polypharmacy. However, data is lacking in identifying and addressing potential DRPs in cancer patients in China. This study ai...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797392/ https://www.ncbi.nlm.nih.gov/pubmed/35116495 http://dx.doi.org/10.21037/tcr-20-3164 |
_version_ | 1784641541567938560 |
---|---|
author | Zhang, Jianping Xu, Rong Zhao, Xincai Wang, Yonggang Zhu, Wanhu Xiao, Misu Hu, Haiyan Tang, Lina Shen, Zan Guo, Cheng |
author_facet | Zhang, Jianping Xu, Rong Zhao, Xincai Wang, Yonggang Zhu, Wanhu Xiao, Misu Hu, Haiyan Tang, Lina Shen, Zan Guo, Cheng |
author_sort | Zhang, Jianping |
collection | PubMed |
description | BACKGROUND: Cancer has always been a serious health threat for human. Patients with cancer are at high risk of drug-related problems (DRPs) due to multi-morbidity associated polypharmacy. However, data is lacking in identifying and addressing potential DRPs in cancer patients in China. This study aims to investigate the prevalence of DRPs and evaluate the effectiveness of an independent anti-neoplastic medication therapy management (MTM) system in ambulatory cancer patients. METHODS: This is a retrospective study. An independent anti-neoplastic MTM system in Shanghai Jiao Tong University affiliated sixth People's Hospital was established in 2018 with the collaboration of oncologists, clinical pharmacists and software engineers. The system contains an independent clinic of pharmacy and MTM software. The software consisted of six modules to help clinical pharmacists serve the tumor patients. The six modules include medication therapy review, intervention plan, personal medication record, medication-related action plan, intervention and/or referral, and documentation and follow-up. RESULTS: A total of 173 eligible tumor patients visited the anti-neoplastic pharmaceutical clinic and were recorded in the independent anti-neoplastic MTM system from Jun 2018 to May 2019. The average clinic visits were 2.4 times of the study participants. Two thirds patients (117/173) had one or more identified DRPs in medication therapy review. Adverse drug reaction, potential drug interaction and non-adherence were the leading DRPs. 85.8% of DRPs could be resolved (cured or improved) in four weeks. Tumor patients showed medication adherence reached 84–100% after three or four times of follow-up and intervention. CONCLUSIONS: The participation of clinical pharmacists in managing polypharmacy tumor patients, with the independent anti-neoplastic MTM system, facilitated the identifying and solving DRPs, especially improving medication adherence of patients, and thus enhancing the effectiveness, safety and rational use of medication. |
format | Online Article Text |
id | pubmed-8797392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87973922022-02-02 The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients Zhang, Jianping Xu, Rong Zhao, Xincai Wang, Yonggang Zhu, Wanhu Xiao, Misu Hu, Haiyan Tang, Lina Shen, Zan Guo, Cheng Transl Cancer Res Original Article BACKGROUND: Cancer has always been a serious health threat for human. Patients with cancer are at high risk of drug-related problems (DRPs) due to multi-morbidity associated polypharmacy. However, data is lacking in identifying and addressing potential DRPs in cancer patients in China. This study aims to investigate the prevalence of DRPs and evaluate the effectiveness of an independent anti-neoplastic medication therapy management (MTM) system in ambulatory cancer patients. METHODS: This is a retrospective study. An independent anti-neoplastic MTM system in Shanghai Jiao Tong University affiliated sixth People's Hospital was established in 2018 with the collaboration of oncologists, clinical pharmacists and software engineers. The system contains an independent clinic of pharmacy and MTM software. The software consisted of six modules to help clinical pharmacists serve the tumor patients. The six modules include medication therapy review, intervention plan, personal medication record, medication-related action plan, intervention and/or referral, and documentation and follow-up. RESULTS: A total of 173 eligible tumor patients visited the anti-neoplastic pharmaceutical clinic and were recorded in the independent anti-neoplastic MTM system from Jun 2018 to May 2019. The average clinic visits were 2.4 times of the study participants. Two thirds patients (117/173) had one or more identified DRPs in medication therapy review. Adverse drug reaction, potential drug interaction and non-adherence were the leading DRPs. 85.8% of DRPs could be resolved (cured or improved) in four weeks. Tumor patients showed medication adherence reached 84–100% after three or four times of follow-up and intervention. CONCLUSIONS: The participation of clinical pharmacists in managing polypharmacy tumor patients, with the independent anti-neoplastic MTM system, facilitated the identifying and solving DRPs, especially improving medication adherence of patients, and thus enhancing the effectiveness, safety and rational use of medication. AME Publishing Company 2021-04 /pmc/articles/PMC8797392/ /pubmed/35116495 http://dx.doi.org/10.21037/tcr-20-3164 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Original Article Zhang, Jianping Xu, Rong Zhao, Xincai Wang, Yonggang Zhu, Wanhu Xiao, Misu Hu, Haiyan Tang, Lina Shen, Zan Guo, Cheng The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients |
title | The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients |
title_full | The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients |
title_fullStr | The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients |
title_full_unstemmed | The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients |
title_short | The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients |
title_sort | effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797392/ https://www.ncbi.nlm.nih.gov/pubmed/35116495 http://dx.doi.org/10.21037/tcr-20-3164 |
work_keys_str_mv | AT zhangjianping theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT xurong theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT zhaoxincai theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT wangyonggang theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT zhuwanhu theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT xiaomisu theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT huhaiyan theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT tanglina theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT shenzan theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT guocheng theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT zhangjianping effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT xurong effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT zhaoxincai effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT wangyonggang effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT zhuwanhu effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT xiaomisu effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT huhaiyan effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT tanglina effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT shenzan effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients AT guocheng effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients |